MAPK3 and nasopharyngeal carcinoma: Our team found that the MAPK/ERK1/2 signaling pathway is highly activated in nasopharyngeal carcinoma cells, and inhibition of this pathway can induce apoptosis in nasopharyngeal carcinoma cells.